Table 2.
Baseline characteristics of women with COVID-19 who died during the follow-up period (1 January to 21 June 2020) in the Oxford-RCGP RSC database.
| Total (N = 5,451) | Non-decedent (N = 4,787) | Decedent (N = 664) | |
|---|---|---|---|
| Age (years) | 59.0 (21.7) | 55.7 (20.8) | 82.5 (11.3) |
| Ethnicity recorded | 4,356 (79.9) | 3,838 (80.2) | 518 (78.0) |
| White | 3,534 (64.8) | 3,064 (64.0) | 470 (70.8) |
| Asian | 510 (9.4) | 484 (10.1) | 26 (3.9) |
| Black | 211 (3.9) | 200 (4.2) | 11 (1.7) |
| Mixed other | 101 (1.9) | 90 (1.9) | 11 (1.7) |
| IMD quintile recorded | 5,326 (97.7) | 4,671 (97.6) | 655 (98.6) |
| 5 (least deprived) | 1,136 (20.8) | 993 (20.7) | 143 (21.5) |
| 4 | 1,088 (20.0) | 936 (19.6) | 152 (22.9) |
| 3 | 1,054 (19.3) | 918 (19.2) | 136 (20.5) |
| 1 and 2 (most deprived) | 2,048 (37.6) | 1,824 (38.1) | 224 (33.7) |
| Settlement or population density | 5,328 (97.7) | 4,671 (97.6) | 657 (98.9) |
| Rural | 933 (17.1) | 816 (17.0) | 117 (17.6) |
| Urban | 4,395 (80.6) | 3,855 (80.5) | 540 (81.3) |
| BMI recorded | 5,122 (94.0) | ||
| BMI (kg/m2) | 28.2 (7.3) | 28.4 (7.3) | 26.6 (7.1) |
| Smoking status recorded | 5,328 (97.7) | 4,684 (97.8) | 26.6 (7.1) |
| Non-smoker | 2,128 (39.0) | 1,912 (39.9) | 216 (32.5) |
| Active-smoker | 486 (8.9) | 446 (9.3) | 40 (6.0) |
| Ex-smoker | 2,714 (49.8) | 2,326 (48.6) | 388 (58.4) |
| Co-morbiditya | 3,001 (55.1) | 2,454 (51.3) | 547 (82.4) |
| All medicationsb | 2,452 (45.0) | 1,980 (41.4) | 472 (71.1) |
Includes hypertension, coronary heart disease, diabetes (type 1 or type 2), chronic kidney disease stage 3–5, asthma, COPD, immunocompromised.
Includes antihypertensive medication, lipid-lowering medication, hypoglycaemic medication, inhalers, immunosuppressants.